I migliori medici per il trattamento di Tumore della prostata - TOP-148 medici

Il Professor Bülent Karagöz è specializzato in oncologia medica con oltre 20 anni di esperienza, concentrandosi sulla biologia dei tumori e sull'immunoterapia presso l'Anadolu Medical Center.

• Responsabile dei Dipartimenti di Oncologia Medica presso istituzioni prestigiose
• Autore di oltre 40 pubblicazioni nella ricerca sul cancro
• Membro dell'Associazione Turca di Oncologia Medica
• Professore presso la Facoltà di Medicina dell'Università Okan di Istanbul

Il Prof. Dr. Ilker Tinay è specializzato in prostatectomia robotica con Da Vinci presso l'Anadolu Medical Center, un leader nell'oncologia urologica.

• Esperto in chirurgia mini-invasiva e ricostruzione della neo-vescica
• Membro del Comitato Esecutivo dell'Associazione di Urooncologia
• Segretario del Gruppo di Ricerca sui Tumori della Vescica
• Membro dell'Associazione Europea di Urologia e del Collegio Americano dei Chirurghi
• Parla inglese e tedesco

Dr. Kezban Berberoglu is a professor of nuclear medicine at Anadolu Medical Center in Istanbul. She completed training at the Johns Hopkins University School of Medicine in Baltimore. Dr. Berberoglu specializes in nuclear oncology and nuclear cardiology. She treats thyroid and prostate cancers using radioisotope therapies. She is a member of the European Association of Nuclear Medicine.

• Performs Lutetium-177 and Actinium-225 therapies for oncology patients.
• Expert in PET-CT imaging using Gallium 68 for oncology cases.
• Member of the Turkish Nuclear Medicine Association cardiology work group.
• Works at an MTQUA Top 10 world hospital affiliated with Johns Hopkins.

Con oltre 900 interventi eseguiti, il dottor Solak porta una vasta esperienza nel trattamento del cancro alla prostata da istituzioni di primo livello come il MD Anderson Cancer Center.

• 19 anni di esperienza in oncologia medica
• Formazione specialistica presso l'Istituto dei Tumori dell'Università di Hacettepe
• Specializzato in casi oncologici complessi in vari tipi di cancro
• Ha contribuito allo sviluppo dell'oncologia clinica nei principali centri

Il Dott. Tanrikulu lavora come parte del team esperto in cancro alla prostata del Centro Medico Anadolu, apportando competenze specialistiche in oncologia medica e terapie sistemiche.

• Specialista in oncologia medica da oltre 7 anni
• Contribuisce a revisioni multidisciplinari per ogni paziente con cancro alla prostata
• Partecipazione attiva a studi di ricerca clinica internazionali
• Ex responsabile dell'unità di oncologia medica presso un importante ospedale di formazione
• Detiene un titolo accademico di Professore Associato

Dr. Gorkem Turkkan is a radiation oncologist at Hisar Hospital Intercontinental in Istanbul. He has successfully completed over 2,500 radiotherapy sessions using MR-Linac technology. Dr. Turkkan focuses on MRI-guided radiotherapy and stereotactic treatments for various cancers. He conducted clinical research on proton therapy at the MAASTRO Clinic in the Netherlands.

• Specializes in prostate, breast, lung, and head and neck cancer treatments.
• Uses VMAT and IMRT techniques to target tumors with precision.
• Maintains membership in the European Society of Radiotherapy and Oncology.
• Works at a JCI-accredited hospital serving 500,000+ patients annually.

Il Prof. Galceran dirige l'Unità di Cancro Genitourinario della Spagna presso il Vall d'Hebron, specializzandosi nel cancro alla prostata con oltre 900 procedure e sperimentazioni cliniche nazionali.

• 37 anni di esperienza in oncologia genitourinaria
• Pioniere nell'immunoterapia e nella diagnostica molecolare del cancro alla prostata
• Autore di oltre 120 articoli sottoposti a peer review su terapie oncologiche
• Co-fondatore del Gruppo Spagnolo per i Tumori Genitourinari (SOGUG)
• Membro di ASCO ed ESMO con Certificazione Europea in Oncologia

Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.

Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.

Dr. Zulfu Sertkaya is an associate professor and andrologist at Andro Expertise in Istanbul. He holds the FEBU title from the European Association of Urology. Dr. Sertkaya focuses on male health, sexual function, and aesthetic urological procedures. He treats patients at his clinic and performs surgeries at affiliated hospitals.

• Earned Fellow of the European Board of Urology (FEBU) status.
• Specialize in andrology, male sexual health, and aesthetic urology.
• Performs penile implant surgery and varicocelectomy for infertility.
• Works at a clinic accredited by the Turkish Medical Association.

Il Prof. Dr. Markus Heuser esegue circa 3.000 interventi chirurgici all'anno – un leader in uro-oncologia presso il Klinikum Solingen.

• Specializzato in procedure minimamente invasive e assistite da robot come la prostatectomia Da Vinci
• Capo del Dipartimento di Urologia con oltre 40 pubblicazioni scientifiche
• Vincitore di prestigiosi premi, incluso il Premio August Kürten
• Insegna urologia all'Università di Göttingen

Il Prof. David Sarid dirige il dipartimento di uro-oncologia presso il Sourasky Medical Center, specializzato in cancro alla prostata. Addestrato all'Università di Oxford in uro-oncologia e tumori prostatici.

• Medico capo dell'oncologia e della radioterapia per il cancro alla prostata
• Oltre 15 anni di esperienza nel trattamento dei tumori urologici nei principali ospedali israeliani
• Investigatore principale in studi clinici per nuove terapie contro il cancro
• Presidente del gruppo GU nell'Associazione Nazionale Oncologica di Israele
• Ha pubblicato più di 30 articoli di ricerca sul trattamento del cancro

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

Il medico è un esperto di fama mondiale in oncologia radioterapica, con un focus sul trattamento del cancro alla prostata. Specializzandosi in tecniche avanzate come Gammaknife, Cyberknife, SIRT e IMRT, il medico guida il Dipartimento di Oncologia Radioterapica al Centro Médico Teknon dal 1999.<\/p>

Con una formazione estesa in istituzioni prestigiose come l'Ospedale Universitario di Sant Pau, il Royal Marsden Hospital e il Laboratorio di Ciclotrone di Harvard, il medico possiede un dottorato in medicina e chirurgia dall'Università di Ginevra.<\/p>

Vincitore del Premio Varian per l'Oncologia Radioterapica, il medico ha scritto oltre 100 pubblicazioni scientifiche e collabora con il CERN in ricerche correlate.<\/p>

Il Prof. Merimsky dirige l'Unità di Oncologia dei Tessuti Molli e dell'Ossa presso il Sourasky Medical Center, specializzata in casi complessi di sarcoma.

• Oltre 25 anni di esperienza in oncologia
• Fellowship presso l'Institut Gustave Roussy di Parigi
• Membro della Facoltà di Sarcoma dell'ESMO e dell'ASCO
• Ha pubblicato ampiamente sui risultati dell'oncologia ortopedica

Dr. Altay Aliyev is a clinical oncologist at Liv Bona Dea Hospital Baku. He specializes in chemotherapy, immunotherapy, and targeted treatments for various cancers. Dr. Aliyev completed a fellowship as a research associate at the Cleveland Clinic. He treats complex conditions like glioblastoma, metastatic breast cancer, and colorectal tumors.

• Expertise covers cytotoxic chemotherapy, hormone therapy, and palliative oncological care.
• Published research on tumor markers in thyroid cancer and breast cancer chemotherapy.
• Formerly served as a research associate in the Cleveland Clinic Endocrinology Department.
• Practices at Liv Bona Dea Hospital, a JCI-accredited facility in Azerbaijan.

Prof. Dr. Önder SÜRGİT is a General Surgeon in the General Surgery Clinic. Working hours: 09:00–18:00. Core practice areas include laparoscopic surgery, cancer surgery, and bariatric surgery.

Graduated from Hacettepe Faculty of Medicine in 1995. Academic title: Professor. Served as Instructor Surgeon at ITEM (Advanced Medical Technologies Training Center). Held faculty roles at Turgut Özal University and Atılım University, Faculties of Medicine. Also worked at Ankara Medicana Hospital and Optimed Health Group. Foreign language: English.

Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.

He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.

Education/Academic Experience

Apr 1995 – Oct 2001                Medical School of Aristotle University of Thessaloniki, Greece

Mar 2007                                   IELTS Certificate (Overall Band Score 7.5)

Feb 2011                                    CCST in Urology, Aristotle University of Thessaloniki, Greece

June 2012                                  Fellow of the European Board of Urology (FEBU)

Sept 2014                                  Fellow in Andrology/Reconstructive Surgery (Mr Giulio Garaffa,         UCLH / Mid-Essex)

Apr 2016                                   Fellow of the Royal College of Surgeons of England (FRCS Eng)

Oct 2018                                   Honorary Senior Lecturer St Andrews University

Sep 2019                                   Urology ChM Tutor in Andrology and Minimally Invasive Surgery (MIMS) University of Edinburgh

Aug 2020                                  European Union Expert Panel Member of in vitro Medical Devices (EU EXPAMED)

Current and Previous appointments

Current appointment

May 2022- Present         Consultant Urologist German Oncology Centre, Limassol, Cyprus

Previous appointments

Nov16- May 2021       Consultant Urological Surgeon Victoria/ Queen Margaret Hospital Fife, Scotland.

Nov 2012 - Oct 2016      Consultant Urologist Broomfield Hospital, Mid-Essex Hospitals Trust 

Jan 2011 - Oct 2012      Urology Clinical Research Fellow, Spelialist Registrar Level), Bristol Royal Infirmary, United Bristol Hospitals Trust

Dec 2009 -Dec 2010      Urology Resident G. Gennimatas Hospital, Aristotle University of Thessaloniki

Duties

• Performing routine and major Penile / Urethral Reconstruction as well as Core Urology procedures twice weekly at Victoria and Queen Margaret Hospitals (Green light prostatectomy, Urolift Service lead, Prostate template biopsies, General urology)

Consultant Urologist providing and supervising the services of andrology and urethral reconstruction surgery. Also covering a general urology one stop outpatient clinics three times per week (Victoria and Queen Margaret Hospitals).

Participation in once weekly local cancer and once monthly specialist male uro-genital reconstruction MDT meetings (Honorary contract at the Western General Hospital, Edinburgh) as well as grand ward rounds.

Undergraduate student trainer and member of examiners panel at St Andrews University, Scotland.

Participation in 1:9 on call Urology Consultant rota.

Research

• Victoria Hospital, Kirkcaldy (NHS Fife) lead investigator. A prospective, multicentre study with subgroup randomisation into MRI-U/S image fusion guided prostate biopsies and routine transrectal U/S guided biopsies.  (MULTIPROS Study)
•  
• Broomfield Hospital (MEHT) sub-investigator. A pragmatic multicentre randomised superiority trial of open urethroplasty versus endoscopic urethrotomy. (OPEN Study)
•  
• Broomfield Hospital (MEHT) sub-investigator. A Multicentre randomised controlled trial of extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic treatment, for ureteric stones. (TISU
• Study)
•  
• Bristol Royal Infirmary sub-investigator. A Multicentre Randomised Controlled Trial of the Use of Drug Therapy in the Management of Symptomatic Ureteric Stones in Hospitalised Patients. (SUSPEND Study)
•  
• Bristol Royal Infirmary sub-investigator. A Multicentre Prospective Single Arm Intervention Trial Evaluating Focal Therapy using High Intensity Focused Ultrasound (Sonablate 500) for Localised Prostate Cancer. (HIFU INDEX Study)
•  
• Bristol Royal Infirmary sub-investigator, A Randomised Controlled Trial to Determine the Effect of Decapeptyl on Reduction of Prostate Volume Pre-Radiotherapy Compared with Standard Therapy (Zoladex). (EDVART Study)

Teaching Experience

Fife Simulation BPH Course Fascilitator (Scottish Urology Training Programme, Queen Margaret Hospital, Dumfermline Fife)

Urology Simulation boot camp Faculty member (St James's University Hospital, Leeds)

General Practitioner Urology Training Programme Fascilitator (ScotGem)

Objective Structured Clinical Examination (OSCE) assessor (St Andrews University Medical School)

Teaching (case-based discussions) and trainee supervision in theatres (East Anglia / East of   Scotland Deaneries trainees)

FY1 Doctors Urology teaching Bristol Royal Infirmary (University Bristol Hospitals Trust)

Undergraduate teaching of medical students in General Hospital of the city of Drama, Greece

Anatomy, Physiology and First Aid to Undergraduate nursing students

Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in gastrointestinal oncology and the treatment of liver cancer. Dr. Sağlam was nominated for the International Best Researcher Award for his work on liver-transplanted patients. He has served as a professor of medical oncology since 2016.

• Member of the European Society for Medical Oncology (ESMO).
• Active member of the American Society of Clinical Oncology (ASCO).
• Member of the European Neuroendocrine Tumor Society (ENETS).
• Works at JCI-accredited facility with advanced PET-MRI and radiology departments.

Il medico dirige il Dipartimento di Urologia e trapianto di rene presso il Centro Medico Teknon a Barcellona, Spagna, con oltre 30 anni di esperienza. Specializzandosi in uro-oncologia e trapiantologia, il medico ha supervisionato oltre 500 operazioni di successo, concentrandosi su patologie del sistema urogenitale utilizzando metodi minimamente invasivi, inclusi interventi laparoscopici e assistiti da robot.<\/p>

Il medico è particolarmente noto per la sua esperienza nel trattamento del cancro alla prostata e utilizza il sistema robotico Da Vinci per procedure chirurgiche innovative. Inoltre, il medico tratta patologie congenite nei bambini come il criptorchidismo ed è membro della Confederazione Urologica Americana, dell'Associazione Urologica Spagnola e della Società Europea di Urologia.<\/p>